"How can you help in Norfolk during the coronavirus (COVID-19) pandemic? Give Blood: Please make an appointment to donate mid-April and after, if you are healthy and feeling well, by using the Red Cross Blood Donor App, visiting the Red Cross website or calling 1-800-RED CROSS (1-800-733-2767).Donate: Support all of the urgent humanitarian needs of the American Red Cross by donating to Where It Is Needed Most at the Red Cross Website or call 1-800-RED CROSS (1-800-733-2767). A donation of any size makes a difference. Volunteer: Our need for volunteers is constant and continues to evolve as we navigate this health crisis. Visit the Red Cross Website for opportunities, including supporting blood donations and providing help from home."

During the past decade, American Red Cross Mid-Atlantic Research Facility conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "American Red Cross Mid-Atlantic Research Facility" are "Whole Blood Donation and Leukoreduction" (1 trials) and "Whole Blood Donations and Leukoreduction" (1 trials). Many other conditions were trialed in "American Red Cross Mid-Atlantic Research Facility" in a lesser frequency.

Most popular intervention types in "American Red Cross Mid-Atlantic Research Facility" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Hemanext One" (1 trials) and "Hemanext Red Blood Cell Processing System" (1 trials). Other intervention names were less common.

The vast majority of trials in "American Red Cross Mid-Atlantic Research Facility" are 2 trials for "All" genders.

Currently, there are NaN active trials in "American Red Cross Mid-Atlantic Research Facility". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in American Red Cross Mid-Atlantic Research Facility, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in American Red Cross Mid-Atlantic Research Facility, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".